Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.
Journal Information
Full Title: Acta Pharmacol Sin
Abbreviation: Acta Pharmacol Sin
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Competing interests The authors declare no competing interests."
Funding Disclosure
Evidence found in paper:
"This work was supported by the National Natural Science Foundation (No. 81973320, No.81673509, and No. 81903714) of China and the Macau Science and Technology Development Fund (FDCT) (No.0002/2019/APD, 067/2018/A2, 033/2017/AMJ, and 0007/2019/AKP)."
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025